- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Type 2 Diabetes Linked to Higher Mortality After Ischemic and Nonischemic Heart Failure: Study

A study published in Diabetes, Obesity and Metabolism has revealed that individuals with type 2 diabetes face significantly higher mortality rates following both ischemic and nonischemic heart failure compared to non-diabetics. Among those with ischemic heart failure, mortality was 26% higher in women and 23% higher in men. For nonischemic heart failure, mortality was 24% higher in women and 20% higher in men. The study was published by Panchal K. and colleagues.
The study examined data on adults recently diagnosed with type 2 diabetes in the period 2000 to 2021. They were matched to between zero and four individuals without diabetes by sex, year of birth, and general practice, to form a well-matched comparative cohort. Incident heart failure (HF) was categorized into two groups: ischaemic (after an earlier ischaemic heart disease event) and non-ischaemic (without such an event). The aim was to investigate all-cause mortality in these populations after an HF diagnosis, employing hazard ratios (HRs) that were adjusted for different socio demographic as well as clinical variables.
Results
• Of a total of 73,344 individuals with heart failure, 18,296 (24.9%) had ischaemic HF.
• During the study period, 9,584 deaths were in individuals with ischaemic HF and 31,800 deaths in individuals with non-ischaemic HF.
• Age-standardised rates of mortality were consistently elevated in individuals with type 2 diabetes, independent of HF type or sex.
In ischaemic HF:
• Women with diabetes: 19.2 deaths per 100 person-years (95% CI: 18.1–20.3)
• Men with diabetes: 20.4 per 100 person-years (95% CI: 19.5–21.4)
• Women without diabetes: 15.1 per 100 person-years (95% CI: 14.4–15.8)
• Men without diabetes: 16.5 per 100 person-years (95% CI: 15.9–17.1)
For non-ischaemic HF:
• Women with diabetes: 19.5 per 100 person-years (95% CI: 19.0–20.1)
• Men with diabetes: 22.0 per 100 person-years (95% CI: 21.4–22.6)
• Women without diabetes: 16.6 per 100 person-years (95% CI: 16.2–17.0)
• Men without diabetes: 19.4 per 100 person-years (95% CI: 18.9–19.8)
• Hazard ratios (HRs) for death were similarly distributed over sex and HF types:
• Ischaemic HF: HR = 1.26 (95% CI: 1.17–1.36) in women; 1.23 (1.15–1.31) in men
• Non-ischaemic HF: HR = 1.24 (95% CI: 1.19–1.29) in women; 1.20 (1.15–1.25) in men
This research offers robust evidence that type 2 diabetes in patients with heart failure of both ischaemic or non-ischaemic origin increases all-cause mortality significantly. The increased risk was equally present in women and men, pointing to a need to manage diabetes aggressively and comprehensively in all those with heart failure to enhance long-term survival.
Reference:
Panchal, K., Lawson, C. A., Shabnam, S., Khunti, K., & Zaccardi, F. (2025). Mortality risk following ischaemic and non-ischaemic heart failure in people with type 2 diabetes: Observational study in England, 2000-2021. Diabetes, Obesity & Metabolism, 27(7), 3848–3857. https://doi.org/10.1111/dom.16413
Dr Prem Aggarwal, (MD Medicine, DNB Cardiology) is a Cardiologist by profession and also the Co-founder and Chairman of Medical Dialogues. He focuses on news and perspectives about cardiology, and medicine related developments at Medical Dialogues. He can be reached out at drprem@medicaldialogues.in